Pr Yoshiki Arakawa, MD, PhD
Neurosurgery — Kyoto University, Japan
Yoshiki Arakawa
LeadR Profile
Neurosurgery
Subspecialties: Neurology - Oncology - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1997 - 2026
Number : 422
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Predictors of Insufficient Awakening During Awake Surgery: A Single-Center Retrospective Study. brain neoplasms, regression analysis, betamethasone, epilepsy, brain, adrenal cortex hormones, retrospective studies, neoplasms, glioblastoma, therapeutics | Oper Neurosurg | 2026 | 0 |
| Ophthalmological Abnormalities in Cases with Intracranial Aneurysms: A Retrospective Referral-Based Study. carotid artery, internal, carotid arteries, aneurysm, arteries, ophthalmoplegia, subarachnoid hemorrhage, visual fields, signs and symptoms, oculomotor nerve, therapeutics, intracranial aneurysm, paralysis | Clin Ophthalmol | 2026 | 0 |
| Role of antiseizure medication in postoperative late seizure and survival among patients with newly diagnosed glioblastoma: A multicenter retrospective study. incidence, retrospective studies, glioblastoma, seizures | Neurooncol Adv | 2026 | 0 |
| Lower social participation and physical activity in patients with craniopharyngioma or CNS germ cell tumor: Their association with apathy. exercise, cells, neoplasms, craniopharyngioma, healthy volunteers, germ cells, apathy | PCN Rep | 2026 | 0 |
| Correction: Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells. microglia, cells, neoplasms | Cancer Res | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| ONC201 in H3 K27M mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) NCT05580562 — radiotherapy, glioma, thalamus, capsules, histones, body weight, therapeutics | Phase 3 | Recruiting | 2023 |
LeadR Networks
Main global connection map